Pressure‐Gradient Counterwork of Dual‐Fuel Driven Nanocarriers in Abnormal Interstitial Fluids for Enhancing Drug Delivery Efficiency
Source abstract
Abstract
Abstract The abnormal pressure in tumor tissue is a significant limitation on the drug delivery efficiency of tumor therapy. This work reports a gradient‐driven nanomotor as drug nanocarrier with the pressure‐counterworking function. The dual‐fuel nanomotors are formed by co‐electrospinning of the photosensitive polymers with calcium peroxide (CaO2) and catalase (CAT), followed by ultraviolet (UV) irradiation and bovine serum albumin (BSA) incubation. The UV‐responsive cleavage nanomotors can effectively release O2 molecules at the fractures as a driving force to increase the delivery speed and escape the phagocytosis of macrophage system in normal tissues. Furthermore, CAT catalyzes H2O2 produced by CaO2 and the tumor interstitial fluids to provide stronger power for the nanomotors. Additionally, according to the analysis of directional motions of the nanomotors, the functional relationship between the rotational diffusion coefficient (DR) and the physiological viscosity is constructed. The dual‐fuel nanocarriers enable up to 13.25% of the injected dose (ID)/per gram tissue and significantly improve the penetration in deep tumor. It is of vital importance to design and obtain the adaptive pressure‐gradient counterworking nanomotors, which can effectively improve the drug delivery efficiency in vitro and in vivo.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Micro and Nano Robotics · Cellular Mechanics and Interactions · Molecular Communication and Nanonetworks
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Biomedical Engineering College of Medicine Southwest Jiaotong University Chengdu Sichuan 610031 China
Funding
Fundamental Research Funds for the Central Universities
References (50)
Show source-provided references
1. 10.1038/s41563-020-0755-z10.1038/s41563-020-0755-z ↗
2. 10.1038/s41416-018-0327-z10.1038/s41416-018-0327-z ↗
3. 10.1002/adma.20190433710.1002/adma.201904337 ↗
4. 10.1016/j.cub.2020.06.08110.1016/j.cub.2020.06.081 ↗
5. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
6. 10.1039/C9CS00309F10.1039/C9CS00309F ↗
7. 10.7150/jca.1764810.7150/jca.17648 ↗
8. 10.1016/j.semcancer.2020.01.01110.1016/j.semcancer.2020.01.011 ↗
9. Gutmann R. · Cancer Res. · 1992 · 52 · 1993
10. 10.1038/nrc145610.1038/nrc1456 ↗
11. 10.1126/science.aaz086810.1126/science.aaz0868 ↗
12. 10.1021/acs.molpharmaceut.8b0031910.1021/acs.molpharmaceut.8b00319 ↗
13. 10.1016/j.ijpharm.2018.11.04610.1016/j.ijpharm.2018.11.046 ↗
14. 10.1021/acsami.9b0492510.1021/acsami.9b04925 ↗
15. 10.1002/adma.20110476310.1002/adma.201104763 ↗
16. 10.1021/acs.accounts.0c0028010.1021/acs.accounts.0c00280 ↗
17. 10.1021/acs.chemrev.1c0024410.1021/acs.chemrev.1c00244 ↗
18. 10.1039/C8NR00640G10.1039/C8NR00640G ↗
19. 10.1039/C8NR01184B10.1039/C8NR01184B ↗
20. 10.1039/C9CC08294H10.1039/C9CC08294H ↗
21. 10.1002/adfm.20170005610.1002/adfm.201700056 ↗
22. 10.1002/adma.20170755710.1002/adma.201707557 ↗
23. 10.1002/chem.20180510710.1002/chem.201805107 ↗
24. 10.3390/pharmaceutics1207066510.3390/pharmaceutics12070665 ↗
25. 10.1021/acs.accounts.8b0025410.1021/acs.accounts.8b00254 ↗
26. 10.1002/adfm.20170610010.1002/adfm.201706100 ↗
27. 10.1002/adma.20220105110.1002/adma.202201051 ↗
28. 10.1002/idm2.1202110.1002/idm2.12021 ↗
29. 10.1016/j.biomaterials.2020.12016310.1016/j.biomaterials.2020.120163 ↗
30. 10.1007/s10555-006-9037-810.1007/s10555-006-9037-8 ↗
31. 10.1016/j.critrevonc.2021.10328510.1016/j.critrevonc.2021.103285 ↗
32. 10.1021/ja047697z10.1021/ja047697z ↗
33. 10.1021/la061595010.1021/la0615950 ↗
34. 10.1002/smll.20190618410.1002/smll.201906184 ↗
35. 10.1021/bm050357110.1021/bm0503571 ↗
36. 10.1089/wound.2014.053810.1089/wound.2014.0538 ↗
37. 10.1021/acsami.8b1768410.1021/acsami.8b17684 ↗
38. 10.1002/adfm.20190244010.1002/adfm.201902440 ↗
39. 10.1039/D0TB00649A10.1039/D0TB00649A ↗
40. 10.1016/j.jconrel.2016.09.01410.1016/j.jconrel.2016.09.014 ↗
41. 10.1371/journal.pcbi.100572410.1371/journal.pcbi.1005724 ↗
42. 10.1038/nrc189310.1038/nrc1893 ↗
43. 10.1016/j.biomaterials.2018.07.02410.1016/j.biomaterials.2018.07.024 ↗
44. 10.1093/nsr/nwab06610.1093/nsr/nwab066 ↗
45. 10.1038/s41467-020-15591-410.1038/s41467-020-15591-4 ↗
46. 10.1002/smll.20140337210.1002/smll.201403372 ↗
47. 10.1038/nchem.267410.1038/nchem.2674 ↗
48. 10.3390/nano1212204910.3390/nano12122049 ↗
49. 10.1002/mabi.20200025110.1002/mabi.202000251 ↗
50. 10.1021/ie071349z10.1021/ie071349z ↗